Alcon Inc (ALC)
88.83
-0.23
(-0.26%)
USD |
NYSE |
May 17, 16:00
88.83
0.00 (0.00%)
After-Hours: 20:00
Alcon Total Assets (Quarterly): 29.56B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 29.56B |
| December 31, 2023 | 29.61B |
| December 31, 2022 | 29.16B |
| September 30, 2022 | 27.80B |
| June 30, 2022 | 27.73B |
| March 31, 2022 | 27.79B |
| December 31, 2021 | 28.00B |
| September 30, 2021 | 27.80B |
| Date | Value |
|---|---|
| June 30, 2021 | 27.75B |
| March 31, 2021 | 27.37B |
| December 31, 2020 | 27.60B |
| September 30, 2020 | 27.41B |
| June 30, 2020 | 27.48B |
| March 31, 2020 | 27.20B |
| December 31, 2019 | 27.66B |
| December 31, 2018 | 27.06B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
27.20B
Minimum
Mar 2020
29.61B
Maximum
Dec 2023
28.00B
Average
27.75B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Novartis AG | 94.33B |
| AC Immune SA | 185.40M |
| CRISPR Therapeutics AG | 2.439B |
| Addex Therapeutics Ltd | 5.526M |
| NLS Pharmaceutics Ltd | 2.270M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.738B |
| Shareholders Equity (Quarterly) | 20.83B |
| Debt to Equity Ratio | 0.2252 |
| Current Ratio | 2.512 |
| Net Debt Paydown Yield | -0.03% |